Operating Expenses Summary of Taiyen Biotech Co., Ltd.

Taiyen Biotech Co., Ltd.'s latest annual operating expenses in 2023 was 897.05 Million TWD , up 7.88% from previous year.
Taiyen Biotech Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 237.74 Million TWD , up 3.95% from previous quarter.
Taiyen Biotech Co., Ltd. reported a annual operating expenses of 831.55 Million TWD in annual operating expenses 2022, down -1.48% from previous year.
Taiyen Biotech Co., Ltd. reported a annual operating expenses of 844.05 Million TWD in annual operating expenses 2021, down -0.03% from previous year.
Taiyen Biotech Co., Ltd. reported a quarterly operating expenses of 237.74 Million TWD for 2024 Q2, up 3.95% from previous quarter.
Taiyen Biotech Co., Ltd. reported a quarterly operating expenses of 214.47 Million TWD for 2023 Q3, up 4.5% from previous quarter.

Annual Operating Expenses Chart of Taiyen Biotech Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Taiyen Biotech Co., Ltd. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	897.05 Million TWD	7.88%
2022	831.55 Million TWD	-1.48%
2021	844.05 Million TWD	-0.03%
2020	844.27 Million TWD	6.79%
2019	790.55 Million TWD	1.02%
2018	782.57 Million TWD	8.57%
2017	720.76 Million TWD	-2.47%
2016	739.01 Million TWD	0.82%
2015	733.01 Million TWD	-2.5%
2014	751.82 Million TWD	3.32%
2013	727.69 Million TWD	0.42%
2012	724.65 Million TWD	-3.15%
2011	748.25 Million TWD	4.58%
2010	715.5 Million TWD	30.64%
2009	547.67 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	244.69 Million TWD	-13.27%
2024 Q2	237.74 Million TWD	3.95%
2023 Q3	214.47 Million TWD	4.5%
2023 FY	897.05 Million TWD	7.88%
2023 Q4	282.14 Million TWD	31.55%
2023 Q1	200.03 Million TWD	-9.52%
2023 Q2	205.23 Million TWD	2.6%
2022 Q1	196.12 Million TWD	-16.03%
2022 Q3	214.45 Million TWD	7.29%
2022 FY	831.55 Million TWD	-1.48%
2022 Q4	221.09 Million TWD	3.09%
2022 Q2	199.88 Million TWD	1.92%
2021 Q2	205.6 Million TWD	7.01%
2021 Q4	233.56 Million TWD	9.79%
2021 Q3	212.74 Million TWD	3.47%
2021 FY	844.05 Million TWD	-0.03%
2021 Q1	192.14 Million TWD	-6.6%
2020 Q2	231.8 Million TWD	15.86%
2020 Q4	205.71 Million TWD	-0.47%
2020 FY	844.27 Million TWD	6.79%
2020 Q1	200.07 Million TWD	-5.23%
2020 Q3	206.68 Million TWD	-10.84%
2019 Q4	211.1 Million TWD	2.64%
2019 Q1	178.99 Million TWD	-18.05%
2019 Q3	205.67 Million TWD	5.59%
2019 FY	790.55 Million TWD	1.02%
2019 Q2	194.78 Million TWD	8.82%
2018 Q3	181.06 Million TWD	-14.17%
2018 Q2	210.96 Million TWD	22.56%
2018 FY	782.57 Million TWD	8.57%
2018 Q4	218.41 Million TWD	20.63%
2018 Q1	172.12 Million TWD	-9.69%
2017 Q1	167.37 Million TWD	-14.13%
2017 FY	720.76 Million TWD	-2.47%
2017 Q4	190.59 Million TWD	7.52%
2017 Q3	177.26 Million TWD	-4.45%
2017 Q2	185.53 Million TWD	10.85%
2016 Q1	160.93 Million TWD	-16.42%
2016 Q4	194.92 Million TWD	8.3%
2016 Q3	179.99 Million TWD	-11.4%
2016 Q2	203.16 Million TWD	26.23%
2016 FY	739.01 Million TWD	0.82%
2015 Q2	188.3 Million TWD	9.42%
2015 Q3	180.06 Million TWD	-4.38%
2015 Q1	172.09 Million TWD	-13.09%
2015 FY	733.01 Million TWD	-2.5%
2015 Q4	192.54 Million TWD	6.93%
2014 FY	751.82 Million TWD	3.32%
2014 Q4	198.01 Million TWD	8.24%
2014 Q3	182.93 Million TWD	-6.02%
2014 Q2	194.65 Million TWD	10.28%
2014 Q1	176.5 Million TWD	-3.61%
2013 Q1	169.12 Million TWD	-11.65%
2013 Q2	197.43 Million TWD	16.74%
2013 Q4	183.1 Million TWD	2.86%
2013 FY	727.69 Million TWD	0.42%
2013 Q3	178.02 Million TWD	-9.83%
2012 Q1	162.88 Million TWD	-16.76%
2012 FY	724.65 Million TWD	-3.15%
2012 Q4	191.41 Million TWD	10.04%
2012 Q2	198.03 Million TWD	21.59%
2012 Q3	173.95 Million TWD	-12.16%
2011 Q3	171.67 Million TWD	-19.05%
2011 Q1	168.82 Million TWD	-15.55%
2011 Q2	212.08 Million TWD	25.62%
2011 Q4	195.66 Million TWD	13.98%
2011 FY	748.25 Million TWD	4.58%
2010 Q2	184.67 Million TWD	17.37%
2010 Q1	157.34 Million TWD	0.0%
2010 Q3	173.56 Million TWD	-6.02%
2010 Q4	199.92 Million TWD	15.19%
2010 FY	715.5 Million TWD	30.64%
2009 FY	547.67 Million TWD	0.0%

Peer Operating Expenses Comparison of Taiyen Biotech Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Farcent Enterprise Co.,Ltd	938.74 Million TWD	4.441%
Mao Bao Inc.	215.26 Million TWD	-316.723%
Sanitar Co., Ltd.	569.01 Million TWD	-57.652%
Chlitina Holding Limited	2.58 Billion TWD	65.348%
Jourdeness Group Limited	1.28 Billion TWD	30.01%
Nan Liu Enterprise Co., Ltd.	517.04 Million TWD	-73.497%
Luo Lih-Fen Holding Co., Ltd.	529.23 Million TWD	-69.501%
San Neng Group Holdings Co., Ltd.	737 Million TWD	-21.716%
Yuen Foong Yu Consumer Products Co., Ltd.	1.49 Billion TWD	39.932%
KNH Enterprise Co., Ltd.	611.8 Million TWD	-46.623%

Global Stocks Search

Taiyen Biotech Co., Ltd. (1737.TW)

Operating Expenses Summary of Taiyen Biotech Co., Ltd.

Annual Operating Expenses Chart of Taiyen Biotech Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Taiyen Biotech Co., Ltd. (2023 - 2009)

Peer Operating Expenses Comparison of Taiyen Biotech Co., Ltd.